TANDEM CAPITAL MANAGEMENT CORP /ADV - UNICYCIVE THERAPEUTICS INC ownership

UNICYCIVE THERAPEUTICS INC's ticker is and the CUSIP is 90466Y103. A total of 13 filers reported holding UNICYCIVE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
TANDEM CAPITAL MANAGEMENT CORP /ADV ownership history of UNICYCIVE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$26,660
+34.4%
31,000
+100.0%
0.01%
-30.8%
Q2 2023$19,840
-39.0%
15,5000.0%0.01%
-43.5%
Q1 2023$32,550
+288.9%
15,5000.0%0.02%
+228.6%
Q4 2022$8,370
-16.3%
15,5000.0%0.01%
-12.5%
Q3 2022$10,000
-23.1%
15,5000.0%0.01%
-20.0%
Q2 2022$13,000
-23.5%
15,5000.0%0.01%
-16.7%
Q1 2022$17,000
-46.9%
15,5000.0%0.01%
-33.3%
Q4 2021$32,000
-27.3%
15,5000.0%0.02%
-35.7%
Q3 2021$44,00015,5000.03%
Other shareholders
UNICYCIVE THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Ayrton Capital LLC 76,645$158,0000.15%
Nantahala Capital Management 686,756$1,415,0000.05%
Board of Trustees of The Leland Stanford Junior University 247,583$510,0000.03%
TANDEM CAPITAL MANAGEMENT CORP /ADV 15,500$32,0000.02%
Frontier Wealth Management LLC 18,800$39,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 26,109$53,0000.00%
MORGAN STANLEY 2$00.00%
BlackRock Inc. 16,045$33,0000.00%
VANGUARD GROUP INC 22,695$47,0000.00%
View complete list of UNICYCIVE THERAPEUTICS INC shareholders